| Course | NUR 324 Research and Evidence-Based Practice |
|---|---|
| Topic | Topic 7 |
| Paper type | Evidence application to a patient |
| Length | About 980 words, 3 pages |
| Format | APA 7 student paper |
| School | Grand Canyon University (GCU) |
| Program | MSN |
| Updated | October 2026 |
Free sample paper for NUR 324 Topic 7
One Patient, One Decision: Tapering a Nightly Sleeping Pill for a 79-Year-Old Woman Who Also Takes Gabapentin
[Author Name]
College of Nursing and Health Care Professions, Grand Canyon University
NUR-324: Research and Evidence-Based Practice
Topic 7 Assignment
[Instructor Name]
February 21, 2028
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
One Patient, One Decision: Tapering a Nightly Sleeping Pill for a 79-Year-Old Woman Who Also Takes Gabapentin
The Patient
Mrs. E. R., 79, is a composite patient from the family practice where I am the care coordination nurse. She has taken zolpidem 5 milligrams every night for six years. She has knee osteoarthritis, for which she takes gabapentin 300 milligrams at bedtime, started eight months ago, and hypertension, well controlled on amlodipine. Her bedroom is upstairs, and nobody else lives with her. Last month she got up at 0300 to use the bathroom, felt unsteady and caught herself on the doorframe. She says: "I don't want to give up my sleeping pill, but I'm scared of falling and ending up in a home. Staying in my house matters more to me than anything."
The Pooled Finding, in Absolute Terms
A meta-analysis of randomized trials of sedative hypnotics in people aged 60 and older with insomnia found small benefits and more frequent harms (Glass et al., 2005). Total sleep time increased by about 25 minutes a night, and the number of awakenings fell slightly. In absolute terms, about 13 people had to be treated for one to report better sleep quality, while about one in every 6 treated had an adverse event, such as memory problems, dizziness, loss of balance or daytime fatigue. Put beside Mrs. R., that means her pill is more likely to be causing her an adverse effect than to be the reason she sleeps well, and the adverse effects it causes are exactly the ones that lead to falls. Relative figures, such as several-fold increases in cognitive and psychomotor events, sound alarming but hide the absolute numbers a patient needs to weigh.
Three Differences From the Trial Samples
Age. The trials enrolled people aged 60 and older, with many in their late 60s and 70s. Mrs. R. is 79. Age might seem to matter, but the meta-analysis already concerns older people, and there is no clear mechanism by which being a few years older than the average participant changes the direction of the finding. This difference does not change the decision.
Duration. The trials were short, most lasting days to a few weeks, while Mrs. R. has taken zolpidem for six years. Long-term users may have developed tolerance, reducing the sleep benefit, and dependence, which makes stopping harder. This affects how to stop, gradually, but not whether stopping is reasonable, since tolerance would reduce the benefit side of the balance further. This difference does not change the decision.
Gabapentin. The trials generally excluded or did not report people taking other sedating drugs. Mrs. R. takes gabapentin at bedtime, which also causes dizziness and sedation. The mechanism is additive: two drugs acting on the central nervous system at the same time increase drowsiness and unsteadiness more than either alone, especially at night when she gets up. This is the difference that matters. It means her risk of the harms in the meta-analysis is likely higher than the trial average, and her near-fall began after gabapentin was added, which fits.
Her Preference, as Evidence With a Weight
Mrs. R. has two preferences that pull against each other: she values her sleep, and she values staying in her own home above everything else. Her own ranking settles the conflict, and in evidence-based practice a patient's values are one of the three sources of evidence alongside research and clinical expertise, not a courtesy added afterward (Melnyk & Fineout-Overholt, 2023). A fall with a fracture is the most likely route to losing her home, and the risk of that is increased by the combination of drugs she is taking. Her preference for independence therefore carries the most weight in this decision, and it points in the same direction as the evidence. Her wish to keep sleeping well still matters and shapes how the change is made: a slow taper with support for sleep, not an abrupt stop.
Weighing the Alternatives
Three alternatives to tapering were considered and set aside. Keeping zolpidem and stopping gabapentin would remove the interaction, but gabapentin was started for knee pain that was keeping her from walking, and pain that limits walking is itself a fall risk. Lowering both doses would reduce the interaction without solving it, and would leave her on two drugs whose benefit in her case is uncertain. Changing to a different sleeping medication would substitute one set of harms for a similar set, since the meta-analysis found adverse effects across the drug classes it included. Tapering zolpidem while keeping gabapentin at its current dose removes the drug with the least favorable balance of benefit to harm and keeps the drug that is doing a clear job. The physician agreed with this order of priority, and the pharmacist reviewed the taper schedule.
The Decision
Decision, with Mrs. R.'s agreement and her physician's order: taper zolpidem over eight weeks, reducing by a quarter of the dose every two weeks, while starting a brief course of cognitive behavioral therapy for insomnia through the practice's nurse-led sleep program. Cognitive behavioral therapy for insomnia has been shown in a meta-analysis of trials to improve sleep in adults with chronic insomnia (Trauer et al., 2015), and it gives her something to replace the pill with. She will also put a nightlight in the bathroom hallway and keep her walker by the bed.
Review date: April 17, four weeks after the taper ends, at a nurse visit to review her sleep diary, any falls or near-falls and how she feels about the change.
The result that would reverse it: if, by the review, her sleep diary shows she is sleeping less than four hours a night despite the therapy and she reports daytime exhaustion that is itself making her unsteady, the decision would be revisited with her physician, including whether the gabapentin dose or timing should change instead.
References
Glass, J., Lanctot, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005). Sedative hypnotics in older people with insomnia: Meta-analysis of risks and benefits. BMJ, 331(7526), 1169. https://doi.org/10.1136/bmj.38623.768588.47
Melnyk, B. M., & Fineout-Overholt, E. (2023). Evidence-based practice in nursing & healthcare: A guide to best practice (5th ed.). Wolters Kluwer.
Trauer, J. M., Qian, M. Y., Doyle, J. S., Rajaratnam, S. M. W., & Cunnington, D. (2015). Cognitive behavioral therapy for chronic insomnia: A systematic review and meta-analysis. Annals of Internal Medicine, 163(3), 191-204. https://doi.org/10.7326/M14-2841
The NUR-324 Topic 7 assignment instructions
Topic 7 in NUR-324 asks students to apply research evidence to a decision about one patient. Strong papers state the pooled finding in absolute terms rather than relative risk, then identify how the patient differs from the trial samples and what those differences mean for applying the result. Students should treat the patient's preference as evidence with a weight, consider alternatives and explain why each was set aside, and reach a decision made with the patient and prescriber. The paper must not present itself as clinical advice; it demonstrates reasoning with evidence for a composite patient described in enough detail to decide.
Inside the NUR 324 Topic 7 example
The finished brief is two pages that end in a decision somebody could sign. It opens with the composite patient described in the detail that matters for this question: age, the two other conditions being managed, what she is already taking, and what she says she wants. The pooled finding is stated in absolute terms beside her. Three differences from the trial sample are then examined one at a time, and only one of the three is judged to matter, with a reason drawn from the mechanism rather than from a feeling that older patients are different. Her preference is written as evidence with a weight, not as a courtesy at the end. The brief closes with a decision, a date to look again, and the single result that would reverse it.
Where the marks sit in the NUR 324 Topic 7 rubric
Faculty reward pooled evidence applied to one person. An Excellent paper states Glass and colleagues' finding in absolute terms, small benefit and more harm from sedative hypnotics in older adults. Credit goes to three differences between Mrs. R. and the trial samples, such as age and gabapentin. The rubric values treating Mrs. R.'s preference as weighted evidence. Strong papers weigh alternatives, such as stopping gabapentin. Top marks go to an eight-week taper with cognitive behavioral therapy for insomnia, supported by Trauer and colleagues, agreed with Mrs. R.
NUR 324 Topic 7 help before you submit
The failure here is a pooled estimate transported onto a patient the study excluded, with no comment on the exclusion, and it is easy to spot because the brief reads the same for any patient. A second loss comes from listing every way the patient differs from the sample and judging none of them, which is caution rather than reasoning. Papers that add patient preference as a final courtesy have not treated it as evidence and graders read the sentence as a rubric item. Relative figures carried into a bedside decision misrepresent the size of what is being offered. Decisions with no review date and no reversing condition are opinions. Clinical advice addressed to a reader belongs nowhere in an academic brief.
Get an NUR-324 Topic 7 example written to your instructions
Send the NUR-324 Topic 7 assignment instructions and the rubric your classroom posts, with the case or patient profile your section supplies. We write a custom example to those criteria, built on a composite patient, with each difference from the studied sample judged and the decision given a reversing condition, in 24 to 48 hours. The first one is free.
More NUR 324 papers and MSN samples
- NUR 324 Topic 1: Evidence Versus Tradition Paper
- NUR 324 Topic 2: PICOT Question Defense
- NUR 324 Topic 3: Reproducible Search Protocol
- NUR 324 Topic 4: Study Design Comparison
- NUR 324 Topic 5: Thin Evidence DQ Pair
- NUR 324 Topic 6: Rapid Critical Appraisal
- NUR 324 Topic 8: Practice Adoption Defense
- NUR 502 Topic 7: Theory Application Paper
- NUR 648EA Topic 7: Failing Evaluation Narrative
- NUR 504 Topic 7: Research Ethics Analysis
- NUR 646EA Topic 7: End to End Alignment Audit
NUR 324 Topic 7 questions, answered
Does an average result apply to one patient?
Only with an argument. An average describes what happened across a group, and the person in front of you sits somewhere in that spread. The work is deciding whether the ways she differs from the studied group are the kind that change the biology, or just the kind that make her unlike the people who volunteered.
How much detail does a composite patient need?
Enough to decide, and no more. Age, the conditions being managed, what is already prescribed and what she has said she wants will usually carry it. Detail that does not bear on the question makes the brief longer without making it better, and the discipline of leaving it out is itself something faculty notice.
Is a paper like this giving clinical advice?
No, and it must not read that way. Everything here is academic work about a composite, de-identified patient, written to show reasoning rather than to direct care. Real decisions belong to the licensed people at the bedside with the full record in front of them. Keep the register analytical and let the argument, not the instruction, do the work.
Where can I find a free NUR 324 Topic 7 sample paper?
The application paper for NUR 324 Topic 7 covers the patient, the pooled finding in absolute terms, three differences from the trial samples, the patient's preference, weighing the alternatives and the decision. Send your NUR 324 Topic 7 prompt and a paper follows free.
Does an average result apply to one patient in NUR 324 Topic 7?
Only with an argument. The paper compares Mrs. R. with the trial samples and explains why the pooled harms likely apply even more strongly in this case.